Lack of interactions between breast cancer resistance protein (bcrp/abcg2) and selected antiepileptic agents.
about
A multi-system approach assessing the interaction of anticonvulsants with P-gpLack of support for a role for RLIP76 (RALBP1) in response to treatment or predisposition to epilepsy.Drug-Resistant Epilepsy: Multiple Hypotheses, Few AnswersOne of the hottest topics in epileptology: ABC proteins. Their inhibition may be the future for patients with intractable seizures.Nanotechnology for delivery of drugs to the brain for epilepsy.MRP isoforms and BCRP mediate sulfate conjugate efflux out of BeWo cells.Epilepsy pharmacogenetics.Genetic Variations of ABCC2 Gene Associated with Adverse Drug Reactions to Valproic Acid in Korean Epileptic PatientsFetoprotective activity of breast cancer resistance protein (BCRP, ABCG2): expression and function throughout pregnancy.Effect of the ATP-binding cassette transporter ABCG2 on pharmacokinetics: experimental findings and clinical implications.Applications of dendrimers for brain delivery and cancer therapy.Effect of Oxidative Stress on ABC Transporters: Contribution to Epilepsy Pharmacoresistance.Tissue distribution and phenobarbital induction of target SLC- and ABC- transporters in cattle.Effective Drug Delivery in Diffuse Intrinsic Pontine Glioma: A Theoretical Model to Identify Potential Candidates.Role of ABCB1, ABCG2, ABCC2 and ABCC5 transporters in placental passage of zidovudine.A comprehensive functional and clinical analysis of ABCC2 and its impact on treatment response to carbamazepineMicroRNA-298 Reverses Multidrug Resistance to Antiepileptic Drugs by Suppressing MDR1/P-gp Expression
P2860
Q28533527-49594455-9881-4EA2-96AD-465D7ABEB2A5Q30361123-1C128664-7355-4843-A9BD-35704EB73746Q33875271-4375AC40-37E7-468E-900F-14CF058B6C2FQ37204397-B87105C8-C011-4E19-B083-D55BD9A20D40Q37426991-B44D0172-D8F5-4E77-B4E8-8B04B1450B45Q37464187-7717F7C3-396D-4756-9881-68CE11D3583FQ37486720-42DE23AC-02FE-432B-862F-655ACCDD044FQ37500912-C6AA69F2-1EE0-4380-9B16-C7DE420EB3A2Q37790379-CE45E01F-49D0-489E-81CF-63A15807E21EQ38071700-1549B77E-B207-480C-A226-0446FD97338CQ38270096-6B3E4149-31AD-40E3-A555-EE8EB75147CCQ39164058-C583D3A3-5C2D-40F5-B07A-F232BDC4DDDCQ46033735-0C373E63-15B5-4C6B-9864-195B27A9F24FQ47100454-C32DB8F1-4A5A-4D99-B7C5-EBCBE856FA77Q53816970-14B7BEB5-7A90-4ADD-A8F6-777846A13E75Q57302598-AC7E662A-A3DB-44CE-8B30-496C246F09AFQ58698331-C1F9D91D-1F90-4F1D-83A8-E7DC2A5181A1
P2860
Lack of interactions between breast cancer resistance protein (bcrp/abcg2) and selected antiepileptic agents.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Lack of interactions between b ...... selected antiepileptic agents.
@en
Lack of interactions between breast cancer resistance protein
@nl
type
label
Lack of interactions between b ...... selected antiepileptic agents.
@en
Lack of interactions between breast cancer resistance protein
@nl
prefLabel
Lack of interactions between b ...... selected antiepileptic agents.
@en
Lack of interactions between breast cancer resistance protein
@nl
P2860
P50
P1433
P1476
Lack of interactions between b ...... selected antiepileptic agents
@en
P2093
Jana Malakova
Zdenek Fendrich
P2860
P304
P356
10.1111/J.1528-1167.2006.00453.X
P577
2006-03-01T00:00:00Z